Guidelines for laboratory monitoring of treatment of peristent virus infections

Research output: Contribution to journalArticle

Authors

  • Deenan Pillay
  • VC Emery
  • MM Ogilvie
  • W Carman
  • K Mutton
  • T Wreghitt
  • D Westmoreland
  • J Breuer
  • M Zuckerman

Colleges, School and Institutes

Abstract

A growing number of antiviral agents are available for treatment of persistent viral infections. This has increased the requirment for virology laboratories to undertake sophisticated assays for monitoring the efficacy of treatment and identifying drug failure at an early stage. The consensus guidelines within this article address the laboratory requirements for monitoring treatment of the herpes viruses, HIV-1, Hepatitis B and Hepatitis C. (C) 2002 Elsevier Science B.V. All rights reserved.

Details

Original languageEnglish
Pages (from-to)73-92
Number of pages20
JournalJournal of Clinical Virology
Volume25
Publication statusPublished - 1 Jan 2002

Keywords

  • HSV, monitoring, antiviral compounds, CMV, MBV, VZV, HIV-1, HCV